Request a quote
With a robust offering specializing in Combination Product Development, we give clients access to the information they need to make confident decisions. Use our request feature to begin our partnership.
Request a Quote →
Container Closure Integrity (CCI)
Container Closure Integrity (CCI) testing is determined by evaluating whether a given container maintains its sterile barrier. It is a mandatory step in the design verification phase of a drug – device combination product development. Several methods exist with different advantages and limitations.
To learn more about our CCI offering, please click link below.
Learn More →Testing services
Combination product development is a complex journey with many potential pitfalls that can cause delays in the development timeline. Learn how ZebraSci can assist you in avoiding these difficulties.
Our commitment to our customers
For more than a decade, ZebraSci has built a legacy based on streamlined solutions, dependable service and technical expertise. We provide pharmaceutical, biotechnology, and medical device companies with development, manufacturing and testing services, helping clients overcome their most difficult primary container and drug delivery device challenges. ZebraSci service capabilities support the development of drug-device combination products with both BD and non-BD devices.
